Antitumoral treatments
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 4, 2012
Grant Date -
Oct 1, 2009
app pub date -
Feb 28, 2007
filing date -
Feb 28, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to combinations of aplidine or aplidine analogues with other titumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully